TRASTUZUMABUM
13 medicamente autorizate în România conțin substanța activă TRASTUZUMABUM.
| Denumire comercială | Concentrație | Formă farmaceutică | Producător | Cod ATC | Prospect |
|---|---|---|---|---|---|
| HERCEPTIN 150mg | 150mg | PULB. PT. CONC. PT. SOL. PERF. | ROCHE DIAGNOSTICS GMBH - GERMANIA | L01FD01 | 📄 Prospect |
| HERCEPTIN 600mg/5ml | 600mg/5ml | SOL. INJ. | ROCHE DIAGNOSTICS GMBH - GERMANIA | L01FD01 | 📄 Prospect |
| HERZUMA 150 mg | 150mg | PULB. PT. CONC. PT. SOL. PERF. | MILLMOUNT HEALTHCARE LTD. - IRLANDA | L01FD01 | 📄 Prospect |
| HERZUMA 420 mg | 420mg | PULB. PT. CONC. PT. SOL. PERF. | MILLMOUNT HEALTHCARE LTD. - IRLANDA | L01FD01 | 📄 Prospect |
| KANJINTI 150 mg | 150mg | PULB. PT. CONC. PT. SOL. PERF. | AMGEN EUROPE B.V. - OLANDA | L01FD01 | 📄 Prospect |
| KANJINTI 420 mg | 420mg | PULB. PT. CONC. PT. SOL. PERF. | AMGEN EUROPE B.V. - OLANDA | L01FD01 | 📄 Prospect |
| OGIVRI 150 mg | 150mg | PULB. PT. CONC. PT. SOL. PERF. | MCDERMOTT LABORATORIES T/A MYLAN DUBLIN BIOLOGICS - IRLANDA | L01FD01 | 📄 Prospect |
| OGIVRI 420 mg | 420mg | PULB. PT. CONC. PT. SOL. PERF. | MCDERMOTT LABORATORIES T/A MYLAN DUBLIN BIOLOGICS - IRLANDA | L01FD01 | 📄 Prospect |
| TRAZIMERA 150 mg | 150mg | PULB. PT. CONC. PT. SOL. PERF. | PFIZER MANUFACTURING BELGIUM N.V. - BELGIA | L01FD01 | 📄 Prospect |
| TRAZIMERA 420 mg | 420mg | PULB. PT. CONC. PT. SOL. PERF. | PFIZER MANUFACTURING BELGIUM N.V. - BELGIA | L01FD01 | 📄 Prospect |
| ZERCEPAC 150 mg | 150mg | PULB. PT. CONC. PT. SOL. PERF. | ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA | L01FD01 | 📄 Prospect |
| ZERCEPAC 420 mg | 420mg | PULB. PT. CONC. PT. SOL. PERF. | ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA | L01FD01 | 📄 Prospect |
| ZERCEPAC 60 mg | 60mg | PULB. PT. CONC. PT. SOL. PERF. | ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA | L01FD01 | 📄 Prospect |
Clase ATC asociate
Substanțe active cu acțiune similară
Alte DCI-uri din aceeași clasă terapeutică: